Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore. Eng, P., Lim, L. H., Loo, C. M., Low, J. A., Tan, C., Tan, E. K., Wong, S. Y., & Setia, S. International Journal of General Medicine, 7:179–191, 2014.
Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore [link]Paper  doi  abstract   bibtex   
The burden of disease associated with Streptococcus pneumoniae infection in adults can be considerable but is largely preventable through routine vaccination. Although substantial progress has been made with the recent licensure of the new vaccines for prevention of pneumonia in adults, vaccine uptake rates need to be improved significantly to tackle adult pneumococcal disease effectively. Increased education regarding pneumococcal disease and improved vaccine availability may contribute to a reduction in pneumococcal disease through increased vaccination rates. The increase in the elderly population in Singapore as well as globally makes intervention in reducing pneumococcal disease an important priority. Globally, all adult vaccines remain underused and family physicians give little priority to pneumococcal vaccination for adults in daily practice. Family physicians are specialists in preventive care and can be leaders in ensuring that adult patients get the full benefit of protection against vaccine-preventable diseases. They can play a key role in the immunization delivery of new and routine vaccines by educating the public on the risks and benefits associated with vaccines. Local recommendations by advisory groups on vaccination in adults will also help to tackle vaccine preventable diseases in adults © 2014 Eng et al.
@article{eng_role_2014,
	title = {Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in {Singapore}},
	volume = {7},
	issn = {1178-7074 (electronic) 1178-7074},
	url = {http://www.dovepress.com/getfile.php?fileID=19492 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=372770844},
	doi = {10.2147/ijgm.s54963},
	abstract = {The burden of disease associated with Streptococcus pneumoniae infection in adults can be considerable but is largely preventable through routine vaccination. Although substantial progress has been made with the recent licensure of the new vaccines for prevention of pneumonia in adults, vaccine uptake rates need to be improved significantly to tackle adult pneumococcal disease effectively. Increased education regarding pneumococcal disease and improved vaccine availability may contribute to a reduction in pneumococcal disease through increased vaccination rates. The increase in the elderly population in Singapore as well as globally makes intervention in reducing pneumococcal disease an important priority. Globally, all adult vaccines remain underused and family physicians give little priority to pneumococcal vaccination for adults in daily practice. Family physicians are specialists in preventive care and can be leaders in ensuring that adult patients get the full benefit of protection against vaccine-preventable diseases. They can play a key role in the immunization delivery of new and routine vaccines by educating the public on the risks and benefits associated with vaccines. Local recommendations by advisory groups on vaccination in adults will also help to tackle vaccine preventable diseases in adults © 2014 Eng et al.},
	language = {English},
	journal = {International Journal of General Medicine},
	author = {Eng, P. and Lim, L. H. and Loo, C. M. and Low, J. A. and Tan, C. and Tan, E. K. and Wong, S. Y. and Setia, S.},
	year = {2014},
	keywords = {*Pneumococcus vaccine/ae [Adverse Drug Reaction], *Pneumococcus vaccine/cm [Drug Comparison], *Pneumococcus vaccine/ct [Clinical Trial], *Pneumococcus vaccine/dt [Drug Therapy], *Pneumococcus vaccine/pe [Pharmacoeconomics], *infection prevention, *pneumococcal infection/dm [Disease Management], *pneumococcal infection/dt [Drug Therapy], *pneumococcal infection/ep [Epidemiology], *pneumococcal infection/pc [Prevention], *vaccination, Singapore, Streptococcus pneumonia/dt [Drug Therapy], Streptococcus pneumonia/ep [Epidemiology], Streptococcus pneumonia/pc [Prevention], antibiotic resistance, clindamycin, community acquired pneumonia/dt [Drug Therapy], community acquired pneumonia/pc [Prevention], cost effectiveness analysis, cotrimoxazole, drug cost, drug efficacy, drug response, drug utilization, erythromycin, general practitioner, health education, hospital cost, human, immunogenicity, incidence, mortality, penicillin derivative, placebo, pneumococcal meningitis/ep [Epidemiology], protection, review, risk benefit analysis, single drug dose, tetracycline, unspecified side effect/si [Side Effect]},
	pages = {179--191},
}

Downloads: 0